Contemporary Drug Development in Heart Failure Call for Hemodynamically Neutral Therapies

CIRCULATION-HEART FAILURE

LIPPINCOTT WILLIAMS & WILKINS

1. National Institutes of Health
2. European Union
3. Health Resource Services Administration
4. Food and Drug Administration
5. AuraSense Therapeutics
6. DaVinci therapeutics
7. Relypsa
8. scPharmaceuticals
9. Tricida
10. Pfizer
11. Bayer
12. AstraZeneca
13. Merck
14. Stealth Peptides
15. Sarfez I
16. Forret Laboratories
17. Novartis
18. Johnson Johnson
19. Oxygen Biotherapeutics
20. Juventas Therapeutics
21. Abbott Laboratories
22. Astellas
23. Astra Zeneca
24. Bayer Schering Pharma AG
25. CorThera, Inc
26. Cytokinetics, Inc
27. DebioPharm SA
28. Errekappa Terapeutici (Milan, Italy)
29. GlaxoSmithKline
30. Medtronic
31. Novartis Pharma AG
32. Otsuka Pharmaceuticals
33. Pericor Therapeutics
34. Protein Design Laboratories
35. Sanofi-Aventis
36. Sigma Tau
37. Solvay Pharmaceuticals